ArticleAnnals of medicine and surgery (2012)2025

Navigating the risks and benefits of newly approved Lisocabtagene Maraleucel in mantle cell lymphoma treatment.

Ayesha Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.